-
psnet.ahrq.gov/sites/default/files/2023-01/spotlight_overdose_of_gabapentin_and_oxycodone_in_a_patient_with_end-stage_renal_disease.pdf
January 01, 2023 - dysfunction increases the
risk of toxicity, manifesting as confusion, sedation, myoclonus, and
respiratory depression
-
psnet.ahrq.gov/node/836794/psn-pdf
March 31, 2022 - questionnaire to measure general practitioners' attitudes to their
role in the management of patients with depression
-
psnet.ahrq.gov/sites/default/files/2022-03/final_spotlight_case_mistaken_capacity.pdf
January 01, 2022 - questionnaire to measure general practitioners' attitudes to their role in the management of patients with
depression
-
psnet.ahrq.gov/innovation/affordable-housing-community-offers-seniors-onsite-health-care-coordination-and-support
March 27, 2024 - a complete list of medications taken, along with many validated risk screens, including nutrition, depression
-
psnet.ahrq.gov/node/846171/psn-pdf
July 26, 2022 - has
been associated with an increased risk of social isolation of patients, feelings of anxiety and depression
-
psnet.ahrq.gov/node/60267/psn-pdf
March 01, 2021 - a complete list of medications taken, along with many
validated risk screens, including nutrition, depression
-
digital.ahrq.gov/sites/default/files/docs/hit-cdm-slides-062111.pdf
June 21, 2011 - for patients with chronic
medical conditions including diabetes, obstructive pulmonary
disease, depression
-
www.ahrq.gov/research/findings/final-reports/iomracereport/reldata4.html
May 01, 2018 - Another hospital tracked the increasing portion of patients who were screened for depression in their
-
cdsic.ahrq.gov/sites/default/files/2023-08/Innovation%20Center%20Q2%202023%20Progress%20Report.pdf
January 01, 2023 - visualizes PC CDS metrics involving use of the Patient Health Questionnaire (PHQ-9), a
screening tool for depression
-
digital.ahrq.gov/sites/default/files/Innovation%20Center%20Q2%202023%20Progress%20Report.pdf
October 12, 2023 - visualizes PC CDS metrics involving use of the Patient Health Questionnaire (PHQ-9), a
screening tool for depression
-
hcup-us.ahrq.gov/reports/statbriefs/sb54.pdf
August 01, 2008 - 58,800 3.7% 2.5%
4 Osteoarthritis (degenerative
joint disease) 53,700 3.3% 2.3%
5 Mood disorders (depression
-
meps.ahrq.gov/survey_comp/MEPS_condition_data.pdf
January 01, 2009 - because of (PERSON)’s physical illness or injury, or a mental or emotional problem such as stress
or depression
-
psnet.ahrq.gov/perspective/annual-perspective-topics-medication-safety
April 27, 2022 - interaction [DDI] between opioids and benzodiazepines resulting in an increased risk for fatal respiratory depression
-
digital.ahrq.gov/sites/default/files/docs/digital-healthcare-innovations-engage-empower-slides-10112023.pdf
October 11, 2023 - people who had
• 3+ PCP visits, ET patients improved
more:
o Mental Quality of Life (p = .005)
o Depression
-
www.ahrq.gov/prevention/guidelines/tobacco/clinicians/references/meta/meta03.html
December 01, 2012 - A randomized trial of sertraline as a cessation aid for smokers with a history of major depression.
-
www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/reports/issue-briefs/Telediagnosis-brief2.pdf
August 03, 2020 - , utilization, and cost
of care for a host of chronic diseases, including heart failure, diabetes, depression
-
www.ahrq.gov/news/events/nac/2021-03-nac/nacmtg031821-minutes.html
July 01, 2021 - States that chose to expand programs and especially for persons with serious psychological distress and depression
-
www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/reports/issue-briefs/telediagnosis.pdf
August 03, 2020 - , utilization, and cost
of care for a host of chronic diseases, including heart failure, diabetes, depression
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-infection-prevention-mdro-protocol.pdf
July 01, 2023 - implementation, and unintended outcomes such as less patient-to-healthcare worker contact,
increased depression
-
hcup-us.ahrq.gov/reports/statbriefs/sb138.jsp
July 01, 2012 - higher risk of developing high cholesterol, hypertension, respiratory ailments, orthopedic problems, depression